Test your knowledge on cardiotoxicity in mTNBC

Anthracycline-based chemotherapy is preferred in the metastatic TNBC setting.
True
False
How is cardiotoxicity defined?
Decline in LVEF of at least 10% to a final value of under 50%
Decline in LVEF of 15% to a final value of under 53%
Decline in LVEF of 10% to a final value of under 40%
Decline in LVEF of 15% to a final value of under 33%
Which of the following therapies is not known to be associated with cardiotoxicity?
Trastuzumab deruxtecan
Radiation
Sacituzumab govitecan
Pembrolizumab
Which of the following evaluations should be considered at baseline for patients with mTNBC being treated a potentially cardiotoxic therapy?
24-hour ambulatory monitoring
Cardiac magnetic resonance imaging
Cardiac stress test
Echocardiogram
0
{"name":"Test your knowledge on cardiotoxicity in mTNBC", "url":"https://www.quiz-maker.com/QKU23TJL3","txt":"Anthracycline-based chemotherapy is preferred in the metastatic TNBC setting., How is cardiotoxicity defined?, Which of the following therapies is not known to be associated with cardiotoxicity?","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}
Tools: Poll Maker | Quiz Maker | Super Surveys